Cite
HARVARD Citation
Mousele, C. et al. (2021). Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2. Neurology. 11 (5), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mousele, C. et al. (2021). Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2. Neurology. 11 (5), p. . [Online].